{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:29:34Z","timestamp":1765826974237},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ijrobp.2011.01.025","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T01:49:25Z","timestamp":1305942565000},"page":"1319-1327","source":"Crossref","is-referenced-by-count":21,"title":["Pharmacogenetic Study in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy: Polymorphisms in Thymidylate Synthase, Epidermal Growth Factor Receptor, GSTP1, and DNA Repair Genes"],"prefix":"10.1016","volume":"81","author":[{"given":"David","family":"P\u00e1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Par\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Pertriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Targarona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"del Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agusti","family":"Barnadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Marcuello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Baiget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2011.01.025_bib1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra040958","article-title":"Systemic therapy for colorectal cancer","volume":"352","author":"Meyerhardt","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib4","first-page":"73","article-title":"Thymidylate synthetase\u2014A target enzyme in cancer chemotherapy","volume":"473","author":"Danenberg","year":"1977","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1247\/csf.20.191","article-title":"Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5\u2032-terminal regulatory region of the human gene for thymidylate synthase","volume":"20","author":"Horie","year":"1995","journal-title":"Cell Struct Funct"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib6","first-page":"3249","article-title":"Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers","volume":"19","author":"Kawakami","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib7","first-page":"4096","article-title":"Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression","volume":"7","author":"Kawakami","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib8","first-page":"2898","article-title":"A novel single nucleotide polymorphism within the 5\u2032 tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity","volume":"63","author":"Mandola","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib9","first-page":"6004","article-title":"Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene","volume":"63","author":"Kawakami","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.tpj.6500401","article-title":"A novel G\/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele","volume":"6","author":"Gusella","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.tpj.6500469","article-title":"Transcription factor-binding sites in the thymidylate synthase gene: Predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin?","volume":"8","author":"Pare","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.bjc.6603233","article-title":"Management of advanced colorectal cancer: State of the art","volume":"95","author":"Saundes","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib13","first-page":"4","article-title":"Oxaliplatin: Mechanism of action and antineoplastic activity","volume":"25","author":"Raymond","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib14","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-05-1083","article-title":"ERCC1 and clinical resistance to platinum-based therapy","volume":"11","author":"Reed","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/35077232","article-title":"Genome maintenance mechanisms for preventing cancer","volume":"411","author":"Hoeijmakers","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib16","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0921-8777(95)00054-2","article-title":"Five polymorphisms in the coding sequence of the xeroderma pigmentosum group D gene","volume":"362","author":"Broughton","year":"1996","journal-title":"Mutat Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib18","first-page":"8097","article-title":"Glutathione S-transferase \u03c0 amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors","volume":"63","author":"Cullen","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","article-title":"A multivariate analysis of genomic polymorphisms: Prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer","volume":"91","author":"Stoehlmacher","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0300-483X(03)00288-9","article-title":"Monitoring base excision repair by in vitro assays","volume":"15","author":"Dianov","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2003.10.002","article-title":"Epidermal growth factor receptor: A promising target in solid tumours","volume":"30","author":"Laskin","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib22","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1073\/pnas.91.21.10217","article-title":"A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling","volume":"91","author":"Moriai","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.600.11.2","article-title":"Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib24","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1200\/JCO.2002.07.132","article-title":"Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control\u2014Final report of Intergroup 0114","volume":"20","author":"Tepper","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00000478-200203000-00009","article-title":"Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: Not one millimeter but two millimeters is the limit","volume":"26","author":"Nagtegaal","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib26","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib27","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0360-3016(99)00099-1","article-title":"Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The M. D. Anderson Cancer Center experience","volume":"44","author":"Janjan","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib29","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib30","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1200\/JCO.2001.19.6.1779","article-title":"Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer","volume":"19","author":"Villafranca","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10350-007-0264-z","article-title":"Germline polymorphisms may act as predictors of response to preoperative chemoradiation in locally advanced T3 rectal tumors","volume":"50","author":"Spindler","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2008.07.008","article-title":"Thymidylate synthase genotypes and tumor regression in stage II\/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation","volume":"272","author":"Stoehlmacher","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib33","article-title":"Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy","author":"Cecchin","year":"2010","journal-title":"Pharmacogenomics J Epub"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2217\/pgs.10.51","article-title":"Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: High incidence of somatic mutations and their relation with response","volume":"11","author":"Balboa","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib35","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-010-0826-7","article-title":"Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil","author":"P\u00e1ez","year":"2010","journal-title":"J Cancer Res Clin Oncol Epub"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib36","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1158\/1078-0432.CCR-07-1197","article-title":"Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma","volume":"13","author":"Gosens","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib38","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","article-title":"Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12\/0405-Prodige 2","volume":"28","author":"G\u00e9rard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","volume":"28","author":"Fern\u00e1ndez-Martos","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib40","first-page":"3075","article-title":"A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer","volume":"21","author":"Stoehlmacher","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib41","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1245\/s10434-006-9112-y","article-title":"Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?","volume":"13","author":"Suh","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2011.01.025_bib42","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2006.08.1844","article-title":"Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy","volume":"25","author":"Ruzzo","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161100191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161100191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T22:56:57Z","timestamp":1686092217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161100191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S036030161100191X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2011.01.025","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}